NGEN — NervGen Pharma Corp. Common stock

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for NGEN in the TickerWise workspace.

NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: CA
• Exchange: NASDAQ
• Website: https://www.nervgen.com

Latest SEC filings for NGEN

• 2026-10-166-K/A
• 2026-09-256-K
• 2026-08-136-K
• 2026-07-02SUPPL
• 2026-07-026-K
• 2026-06-016-K
• 2026-05-27EFFECT
• 2026-05-266-K
• 2026-05-26F-10
• 2026-05-26F-X

Latest NGEN news

• 2026-10-01NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything Read article
• 2026-09-30NervGen Pharma Corp. (NGEN) Discusses Challenges and Advances in Drug and Therapy Trials for Spinal Cord Injury Transcript Read article

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.